Rafferty Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4M | Buy |
15,491
+1,895
| +14% | +$489K | 0.01% | 440 |
|
2025
Q1 | $3.04M | Sell |
13,596
-3,054
| -18% | -$684K | 0.01% | 475 |
|
2024
Q4 | $3.81M | Buy |
16,650
+693
| +4% | +$158K | 0.01% | 466 |
|
2024
Q3 | $3.9M | Sell |
15,957
-11
| -0.1% | -$2.69K | 0.01% | 473 |
|
2024
Q2 | $3.06M | Buy |
15,968
+792
| +5% | +$152K | 0.01% | 521 |
|
2024
Q1 | $3.01M | Buy |
15,176
+200
| +1% | +$39.6K | 0.01% | 587 |
|
2023
Q4 | $2.58M | Sell |
14,976
-354
| -2% | -$60.9K | 0.01% | 610 |
|
2023
Q3 | $2.27M | Buy |
15,330
+1,147
| +8% | +$170K | 0.01% | 572 |
|
2023
Q2 | $3.1M | Buy |
14,183
+1,020
| +8% | +$223K | 0.02% | 518 |
|
2023
Q1 | $2.88M | Buy |
13,163
+566
| +4% | +$124K | 0.02% | 518 |
|
2022
Q4 | $2.62M | Buy |
12,597
+4,745
| +60% | +$988K | 0.02% | 510 |
|
2022
Q3 | $1.71M | Buy |
7,852
+4,303
| +121% | +$939K | 0.02% | 544 |
|
2022
Q2 | $744K | Sell |
3,549
-921
| -21% | -$193K | 0.01% | 728 |
|
2022
Q1 | $1.08M | Sell |
4,470
-427
| -9% | -$104K | 0.01% | 763 |
|
2021
Q4 | $1.28M | Buy |
4,897
+257
| +6% | +$67K | 0.01% | 787 |
|
2021
Q3 | $1.22M | Buy |
4,640
+1,411
| +44% | +$372K | 0.01% | 761 |
|
2021
Q2 | $796K | Buy |
3,229
+72
| +2% | +$17.7K | 0.01% | 979 |
|
2021
Q1 | $613K | Buy |
3,157
+139
| +5% | +$27K | ﹤0.01% | 934 |
|
2020
Q4 | $642K | Sell |
3,018
-22
| -0.7% | -$4.68K | 0.01% | 627 |
|
2020
Q3 | $521K | Sell |
3,040
-598
| -16% | -$102K | 0.01% | 687 |
|
2020
Q2 | $698K | Buy |
3,638
+2,153
| +145% | +$413K | 0.01% | 632 |
|
2020
Q1 | $219K | Sell |
1,485
-2,397
| -62% | -$353K | 0.01% | 507 |
|
2019
Q4 | $602K | Buy |
+3,882
| New | +$602K | 0.01% | 663 |
|